Skip to content

Effect of Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass on Gastroesophageal Reflux Disease: An 8-Year Prospective Cohort Study

Effect of Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass on Gastroesophageal Reflux Disease: An 8-Year Prospective Cohort Study.

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03692455
Enrollment
75
Registered
2018-10-02
Start date
2025-09-17
Completion date
2025-11-08
Last updated
2025-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease, Morbid Obesity

Keywords

GERD, Roux-en-Y Gastric Bypass, Vertical Sleeve Gastrectomy, Lion 2.0 Consensus

Brief summary

This study represents a long-term observational follow-up of patients who had previously undergone bariatric surgery (laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass) in the context of an earlier interventional trial (NCT03692455). No new interventions are assigned in the follow-up phase. Participants are evaluated clinically and functionally at predefined intervals using standardized multimodal assessments (symptom questionnaires, endoscopy, manometry, radiology, and pH monitoring).

Detailed description

In order to determine the long term impact of Bariatric surgery on GERD, esophageal syndromes will be evaluated following the Lyon 2.0 Consensus, where troublesome symptoms were defined as score ≥ 2 on a validated questionnaire of symptoms for Portuguese language along with esophageal syndromes with injury assessed through upper endoscopy. Esophageal acid exposure will be determined through 24h pH monitoring. Increased acid exposure will be characterized when total esophageal pH \< 4 for at least 4% of its total monitoring time. The data will be collected 8 years after de surgical intervention.

Interventions

None listed

Sponsors

UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL (UFRGS)
CollaboratorUNKNOWN
Clinica Gastrobese
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 78 Years
Healthy volunteers
No

Inclusion criteria

Patients enrolled in a previous prospective dual-cohort extension with 75 patients of the original Trial. Original Inclusion Criteria: Inclusion criteria were age 18-70 years and body mass index (BMI) ≥40 kg/m², or ≥35 kg/m² with obesity-related comorbidities. A total of 75 patients completed the original trial.

Exclusion criteria

Been previously submitted to any gastroesophageal surgical procedure. Presence of chronical diseases that affects esophageal motility. Do not tolerate any of the required exams

Design outcomes

Primary

MeasureTime frameDescription
Change in number of Participants With Gastroesophageal Reflux Disease (GERD)8 years after interventionPrevalence of GERD in patients will be characterized according to Lyon 2.0 consensus

Secondary

MeasureTime frameDescription
Change in number of Participants With Esophageal Injury8 years after interventionSyndromes with esophageal injury should be determined exclusively by the presence of reflux esophagitis
Change in Total Esophageal Acid Exposure at 24h pH Monitoring8 years after interventionEsophageal acid exposure will be measured through 24h pH monitoring. During such period, esophageal pH will be measured and recorded as the percent of time pH stays below 4.
Change in number of Participants Presenting GERD symptoms8 years after interventionPrevalence of typical reflux syndrome will be evaluated. In order to assess such troublesome symptoms a validated questionnaire translated into Portuguese language will be used.
Change in Esophageal Acid Exposure at 24h pH Monitoring in Supine Position8 years after interventionEsophageal acid exposure will be measured through 24h pH monitoring. Esophageal pH will be measured and recorded as the percent of time pH stays below 4 while participant in supine position
Change in number of Participants With Increased Acid Exposure8 years after interventionIncreased Acid Exposure occurs when esophageal pH is \<4 for a period longer than 4% of the total test time on a 24h pH monitoring.
Change in Esophageal Acid Exposure at 24h pH Monitoring in Upright Position8 years after interventionEsophageal acid exposure will be measured through 24h pH monitoring. Esophageal pH will be measured and recorded as the percent of time pH stays below 4 while participant in upright position

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026